Financials data is unavailable for this security.
View more
Year on year American Oncology Network Inc had net income fall from a gain of 0.00 to a loss of 5.54m despite a 11.27% increase in revenues from 1.15bn to 1.28bn. An increase in the cost of goods sold as a percentage of sales from 91.70% to 93.53% was a component in the falling net income despite rising revenues.
| Gross margin | 4.99% |
|---|---|
| Net profit margin | -5.45% |
| Operating margin | -4.95% |
| Return on assets | -19.18% |
|---|---|
| Return on equity | -693.84% |
| Return on investment | -39.16% |
More ▼
Cash flow in USDView more
In 2023, American Oncology Network Inc increased its cash reserves by 5.99%, or 1.61m. Cash Flow from Financing totalled 55.27m or 4.32% of revenues. In addition the company used 18.12m for operations while cash used for investing totalled 35.53m.
| Cash flow per share | -4.82 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 1.87 |
|---|---|
| Tangible book value per share | 0.8694 |
More ▼
